Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of Oral Allylnitrile Administration on Cochlear Functioning in Mice Following Comparison of Different Anesthetics for Hearing Assessment

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Allylnitrile is a compound found in cruciferous vegetables and has the same lethality and toxic effects as the other nitriles. In 2013, a viable allylnitrile ototoxicity mouse model was established. The toxicity of allylnitrile was limited through inhibition of CYP2E1 with trans-1,2-dichloroethylene (TDCE). The allylnitrile intoxication model has been extensively tested in the 129S1 mouse strain for vestibular function, which showed significant HC loss in the vestibular organ accompanied by severe behavioral abnormalities. However, the effect of allylnitrile on auditory function remains to be evaluated. Commonly used anesthetics to conduct hearing measurements are isoflurane and ketamine/xylazine anesthesia but the effect of these anesthetics on hearing assessment is still unknown. In this study we will evaluate the otovestibular effects of oral allylnitrile administration in mice. In addition, we will compare the influence of isoflurane and ketamine/xylazine anesthesia on hearing thresholds.

          Methods and Materials: Fourteen Coch+/– CBACa mice were randomly allocated into an allylnitrile ( n = 8) and a control group ( n = 6). Baseline measurements were done with isoflurane and 1 week later under ketamine/xylazine anesthesia. After baseline audiovestibular measurements, mice were co-administered with a single dose of allylnitrile and, to reduce systemic toxicity, three intraperitoneal injections of TDCE were given. Hearing loss was evaluated by recordings of auditory brainstem responses (ABR) and distortion product otoacoustic emissions (DPOAE). Specific behavioral test batteries for vestibular function were used to assess alterations in vestibular function.

          Results: Hearing thresholds were significantly elevated when using isoflurane anesthesia compared to ketamine/xylazine anesthesia for all frequencies of the ABR and the mid-to-high frequencies in DPOAE. Allylnitrile-treated mice lacked detectable ABR thresholds at each frequency tested, while DPOAE thresholds were significantly elevated in the low-frequency region of the cochlea and completely lacking in the mid-to high frequency region. Vestibular function was not affected by allylnitrile administration.

          Conclusion: Isoflurane anesthesia has a negative confounding effect on the measurement of hearing thresholds in mice. A single oral dose of allylnitrile induced hearing loss but did not significantly alter vestibular function in mice. This is the first study to show that administration of allylnitrile can cause a complete loss of hearing function in mice.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses.

          The common occurrence of hearing loss in both humans and mice, and the anatomical and functional similarities of their inner ears, attest to the potential of mice being used as models to study inherited hearing loss. A large-scale, auditory screening project is being undertaken at The Jackson Laboratory (TJL) to identify mice with inherited hearing disorders. To assess hearing sensitivity, at least five mice from each inbred strain had auditory brainstem response (ABR) thresholds determined. Thus far, we have screened 80 inbred strains of mice; 60 of them exhibited homogeneous ABR threshold values not significantly different from those of the control strain CBA/CaJ. This large database establishes a reliable reference for normal hearing mouse strains. The following 16 inbred strains exhibited significantly elevated ABR thresholds before the age of 3 months: 129/J, 129/ReJ, 129/SvJ, A/J, ALR/LtJ, ALS/LtJ, BUB/BnJ, C57BLKS/J, C57BR/cdJ, C57L/J, DBA/2J, I/LnJ, MA/MyJ, NOD/LtJ, NOR/LtJ, and SKH2/J. These hearing impaired strains may serve as models for some forms of human non-syndromic hearing loss and aid in the identification of the underlying genes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Disorders of balance and vestibular function in US adults: data from the National Health and Nutrition Examination Survey, 2001-2004.

            Balance dysfunction can be debilitating and can lead to catastrophic outcomes such as falls. The inner ear vestibular system is an important contributor to balance control. However, to our knowledge, the prevalence of vestibular dysfunction in the United States and the magnitude of the increased risk of falling associated with vestibular dysfunction have never been estimated. The objective of this study was to determine the prevalence of vestibular dysfunction among US adults, evaluate differences by sociodemographic characteristics, and estimate the association between vestibular dysfunction and risk of falls. We included data from the 2001-2004 National Health and Nutrition Examination Surveys, which were cross-sectional surveys of US adults aged 40 years and older (n = 5086). The main outcome measure was vestibular function as measured by the modified Romberg Test of Standing Balance on Firm and Compliant Support Surfaces. From 2001 through 2004, 35.4% of US adults aged 40 years and older (69 million Americans) had vestibular dysfunction. Odds of vestibular dysfunction increased significantly with age, were 40.3% lower in individuals with more than a high school education, and were 70.0% higher among people with diabetes mellitus. Participants with vestibular dysfunction who were clinically symptomatic (ie, reported dizziness) had a 12-fold increase in the odds of falling. Vestibular dysfunction, as measured by a simple postural metric, is common among US adults. Vestibular dysfunction significantly increases the likelihood of falls, which are among the most morbid and costly health conditions affecting older individuals. These data suggest the importance of diagnosing, treating, and potentially screening for vestibular deficits to reduce the burden of fall-related injuries and deaths in the United States.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cisplatin ototoxicity and protection: clinical and experimental studies.

              Cisplatin is a chemotherapeutic agent that is widely used to treat a variety of malignant tumors. Serious dose-limiting side effects like ototoxicity, nephrotoxicity and neurotoxicity occur with the use of this agent. This review summarizes recent important clinical and experimental investigations of cisplatin ototoxicity. It also discusses the utility of protective agents employed in patients and in experimental animals. The future strategies for limiting cisplatin ototoxicity will need to avoid interference with the therapeutic effect of cisplatin in order to enhance the quality of life of patients receiving this important anti-tumor agent.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Toxicol
                Front Toxicol
                Front. Toxicol.
                Frontiers in Toxicology
                Frontiers Media S.A.
                2673-3080
                25 February 2021
                2021
                : 3
                : 641569
                Affiliations
                [1] 1Department of Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp, Belgium
                [2] 2Laboratory of Experimental Hematology, Faculty of Medicine and Health Sciences, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp , Antwerp, Belgium
                [3] 3Laboratory of Neurochemistry and Behaviour, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp , Antwerp, Belgium
                [4] 4Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen , Groningen, Netherlands
                [5] 5Department of Neurology, Memory Clinic of Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken , Antwerp, Belgium
                [6] 6Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital , Edegem, Belgium
                [7] 7Department of Anaesthesiology, Antwerp University Hospital , Edegem, Belgium
                Author notes

                Edited by: Agnieszka J. Szczepek, Charité—Universitätsmedizin Berlin, Germany

                Reviewed by: Rosario Vega, Meritorious Autonomous University of Puebla, Mexico; Helena Caria, Institute of Biosystems and Integrative Sciences (BioISI), Portugal

                *Correspondence: Dorien Verdoodt dorien.verdoodt@ 123456uantwerpen.be

                This article was submitted to Neurotoxicology, a section of the journal Frontiers in Toxicology

                †These authors have contributed equally to this work and share first authorship

                Article
                10.3389/ftox.2021.641569
                8915850
                446d6f1b-72a8-420a-be5b-93eaa237b316
                Copyright © 2021 Verdoodt, Eens, Van Dam, De Deyn, Vanderveken, Szewczyk, Saldien, Ponsaerts and Van Rompaey.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 14 December 2020
                : 03 February 2021
                Page count
                Figures: 8, Tables: 0, Equations: 0, References: 59, Pages: 15, Words: 9960
                Funding
                Funded by: Universiteit Antwerpen, doi 10.13039/501100007660;
                Categories
                Toxicology
                Original Research

                anesthesia,auditory brainstem response,dpoae,allylnitrile,vestibular function

                Comments

                Comment on this article